Your job-based insurance cut GLP-1 coverage. Here are some options

Insurance companies are pulling back on covering GLP-1 drugs such as Wegovy when they are used primarily for weight loss, according to a Global Medical Trends Survey from WTW cited by Ideastream. The share of insurers covering weight-loss medications fell from 57% to 53% between 2025 and 2026, while the number considering dropping coverage nearly doubled. Roughly 12% of Americans use GLP-1 drugs, but the list price can range from around $500 to more than $1,000 for a monthly dose or package, making them "very, very costly," said Sharona Hoffman, a professor of law and bioethics at Case Western Reserve University.

Hoffman said many insurers will still cover GLP-1 drugs for medically necessary purposes such as diabetes, sleep apnea, cardiovascular conditions, and kidney disease, but not if a patient's primary motivation is weight loss. "There are other things to do to lose weight — like diet, exercise, and so on — and so they are becoming less willing to pay for this medical intervention," she said. She noted that a diagnosis of obesity alone may not be sufficient for coverage, but appeals can be successful if patients provide documentation of a qualifying health condition. "Appeals will be most successful if the patient can identify (and provide documentation about) a health condition that justifies the use of the GLP-1," she said, adding that "it's always worth appealing because some insurers may cave simply because they face resistance."

For patients who lose coverage, several alternatives exist. Drug makers offer discounted self-pay options: Wegovy self-pay prices start at $150, and Foundayo costs between about $150 and $350 for patients who qualify for Eli Lilly's savings program. Medicare has an 18-month GLP-1 Bridge program that brings the cost of weight-loss drugs to $50 per month. Direct-to-consumer websites and medical spas also sell GLP-1s, but Hoffman warned patients to research carefully. "There has been a lot of concern about unregulated medical spas that might sell you drugs that actually are not the right drug, or not good drugs," she said. "You have to be careful — you can't just believe every ad that you see." She also emphasized that patients obtaining GLP-1 drugs directly should still have medical oversight from a doctor due to potential side effects and drug interactions.